CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Open-Label, Single-Center, Extension Study Evaluating Antibody Persistence Compared to Naïve Children and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Novartis Vaccine as Infants in Study V72P6

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01027351
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:07.694065+00:00
Published At: 2014-05-06T00:00:00+00:00
Record Updated At: 2018-10-09
Results Posted At: 2014-05-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Meningococcal Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-10-09"
protocolSection.identificationModule.nctId: "NCT01027351"
protocolSection.identificationModule.officialTitle: "A Phase 2, Open-Label, Single-Center, Extension Study Evaluating Antibody Persistence Compared to Na\u00efve Children and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB\u00b1OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Novartis Vaccine as Infants in Study V72P6"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-05-06"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.